X4 Pharmaceuticals Inc (NAS:XFOR)
$ 0.371 -0.022 (-5.6%) Market Cap: 63.27 Mil Enterprise Value: 10.25 Mil PE Ratio: 0 PB Ratio: 1.06 GF Score: 30/100

Q4 2020 X4 Pharmaceuticals Inc Earnings Call Transcript

Mar 04, 2021 / 01:30PM GMT
Release Date Price: $9.18 (-5.75%)
Operator

Greetings and welcome to X4 Pharmaceuticals Fourth Quarter Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.

A question and answer session will follow the formal presentation. As a reminder, this conference call is being recorded. It is now my pleasure to introduce your host, Dan Ferry of LifeSci Advisors. Please begin.

Daniel Ferry
LifeSci Advisors - Managing Director

Thank you, operator, and good morning, everyone. Thanks for joining us. Presenting on today's call will be X4's Chief Executive Officer Dr. Paula Ragan, and the company's Chief Financial Officer, Adam Mostafa.

Following prepared remarks by each, we will open up the call to your questions and we'll be joined by Dr. Diego Cadavid, Chief Medical Officer, Art Taveras, Chief Scientific Officer, and Mary DiBiase, Senior Vice President, Technical Operators and Quality.

As a reminder, on today's call, the company will be making forward-looking statements regarding regulatory and product development plans as well as

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot